Gonadotropin-releasing hormone (GnRH) action on uterine leiomyomata is not mediated by uterine GnRH receptors.
作者信息
Neuman M, Langer R, Golan A, Bukovsky I, Caspi E, Koch Y
机构信息
Assaf Harofeh Medical Center, Zerifin, Israel.
出版信息
Fertil Steril. 1991 Aug;56(2):364-6. doi: 10.1016/s0015-0282(16)54503-8.
PMID:1649060
Abstract
摘要
相似文献
1
Gonadotropin-releasing hormone (GnRH) action on uterine leiomyomata is not mediated by uterine GnRH receptors.促性腺激素释放激素（GnRH）对子宫平滑肌瘤的作用并非由子宫GnRH受体介导。
Fertil Steril. 1991 Aug;56(2):364-6. doi: 10.1016/s0015-0282(16)54503-8.
2
[GnRH-analogs in the therapy of uterine myomatosis].
Ther Umsch. 1990 Dec;47(12):951-7.
3
Gonadotropin-releasing hormone specific binding sites in uterine leiomyomata.
Biochem Biophys Res Commun. 1988 May 16;152(3):1326-31. doi: 10.1016/s0006-291x(88)80430-3.
4
Uterine leiomyomata and sterility: therapy with gonadotropin-releasing hormone agonists and leiomyomectomy.
Gynecol Endocrinol. 1997 Jun;11(3):169-74. doi: 10.3109/09513599709152531.
5
Rapid reduction of uterine myomas after short-term treatment with microencapsulated D-Trp6-LHRH.
Lancet. 1986 Nov 22;2(8517):1213. doi: 10.1016/s0140-6736(86)92215-4.
6
A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue.
Am J Obstet Gynecol. 1983 Nov 15;147(6):726-7. doi: 10.1016/0002-9378(83)90463-5.
7
Treatment of uterine fibroids with agonist analogs of gonadotropin-releasing hormone.
Fertil Steril. 1988 Mar;49(3):538-41.
8
Mechanism of LHRH analogue action in uterine fibroids.
Horm Res. 1989;32 Suppl 1:150-3. doi: 10.1159/000181332.
9
An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.通过磁共振成像评估促性腺激素释放激素类似物和醋酸甲羟孕酮对子宫平滑肌瘤体积的影响：一项前瞻性、随机、双盲、安慰剂对照、交叉试验。
J Clin Endocrinol Metab. 1993 May;76(5):1217-23. doi: 10.1210/jcem.76.5.8496313.
10
A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.一项针对子宫平滑肌瘤女性的促性腺激素释放激素激动剂联合雌激素 - 孕激素或孕激素“反加”方案的前瞻性随机试验。
J Clin Endocrinol Metab. 1993 Jun;76(6):1439-45. doi: 10.1210/jcem.76.6.8501148.
Zotero 插件